AstraZeneca sells Alderley Park site
12th Mar 2014 07:29
Pharmaceutical giant AstraZeneca is selling its Alderley Park site in Cheshire to Manchester Science Parks, a Greater Manchester-based public-private partnership and science park operator. The sale is part of AstraZeneca's plan to establish a new global research and development centre and corporat
Read moreThursday broker round-up UPDATE
6th Mar 2014 09:10
Advanced Medical Solutions: Investec ups target price from 97p to 121p and keeps a buy recommendation. African Barrick Gold: Investec increases target price from 132p to 206p, but still recommends selling. Arcontech: Northland shifts target price from 0.20p to 0.24p and keeps a buy recommendation.
Read moreFTSE 100 movers: Majority of stocks in red as risk appetite weakens
3rd Mar 2014 14:20
UK stocks sank to their lowest levels in two weeks today, with escalating tensions in Ukraine prompting a sharp reduction in risk appetite. This saw investors flee towards safe-haven assets, such as gold and silver, today, pushing the share prices of precious metal producers Randgold and Fresnillo
Read moreLondon open: Stocks drop sharply as Ukraine tensions rise
3rd Mar 2014 08:14
- Ukrainian concerns escalate - US condemns Russian military move - Financials fall sharply - Precious metal miners track gold and silver prices higher techMARK 2,867.09 -1.30% FTSE 100 6,744.93 -0.95% FTSE 250 16,488.43 -1.42% UK stocks were sold off sharply on Monday morning on the back of the
Read moreLondon pre-open: Ukraine to weigh heavily on FTSE
3rd Mar 2014 07:24
The FTSE is expected to open notably lower this morning, hit by the most recent developments in the Ukraine and ahead of what is set to be another busy week. City sources predict the FTSE 100 will open around 80 points lower than Friday's close of 6,809.70. The crisis in Ukraine has stepped up a g
Read moreAstraZeneca receives FDA approval for Bydureon diabetes treatment
3rd Mar 2014 07:14
The US Food and Drug Administration (FDA) has approved AstraZeneca's injectable treatment for type 2 diabetes, the pharmaceutical company announced on Monday. Bydureon Pen, the first and only once-weekly medicine for adults with type 2 diabetes, has been given the green light as a supplement to die
Read moreLondon close: Flat finish as unemployment rises
19th Feb 2014 16:21
- UK unemployment rises to 7.2 per cent - BoE MPC vote to maintain interest rates - US housing starts fall 16 per cent techMARK 2,875.58 -0.22% FTSE 100 6,796.71 0.00% FTSE 250 16,347.33 +0.03% The FTSE closed flat as traders digested UK unemployment data, minutes from the Bank of England's most
Read moreFTSE 100 movers: Sports Direct jumps after strong update
19th Feb 2014 14:02
Sports Direct International shot to the top of the risers after group sales in the quarter to January 26th rose 11.2 per cent from the previous year to 655.4m pounds. Gross profit gained 14.6 per cent to 280.7m pounds during the period with growth across all its divisions including Sports Retail, Br
Read moreLondon midday: Stocks slip after surprise increase in jobless rate
19th Feb 2014 11:41
- UK jobless rate rises to 7.2 per cent, above estimates - MPC votes unanimously to leave policy unchanged - Ex-div stocks provide a drag on FTSE - Sports Direct jumps after Q3 update techMARK 2,855.22 -0.93% FTSE 100 6,761.33 -0.52% FTSE 250 16,233.58 -0.66% UK markets pulled back from a four-w
Read moreLondon open: Stocks pause at four-week high ahead of data, BoE minutes
19th Feb 2014 08:16
- Markets at highest since January 22nd - UK labour-market data due out, BoE minutes - Sports Direct, M&S, BAE Systems lead the upside - Ex-div stocks weigh techMARK 2,878.02 -0.14% FTSE 100 6,798.45 +0.03% FTSE 250 16,340.79 -0.01% UK stocks opened more or less flat on Wednesday morning after th
Read moreSunday newspaper round-up: Barclays, RSA, Vodafone
9th Feb 2014 09:06
Barclays is preparing to cut its investment bank by a fifth to appease the Bank of England (BoE), the Sunday Times reported. Chief Executive Antony Jenkins will announce the plan to sell £150bn of assets and slash annual costs by £1.7bn with the bank's full-year results on February 11th. The investm
Read moreLondon midday: Stocks flat as investors await US data with caution
7th Feb 2014 11:41
- Markets flat ahead of US jobs report - Stocks pause after ECB-inspired rally on Thursday - Data disappoints from China, UK, Germany techMARK 2,788.33 +0.33% FTSE 100 6,564.10 +0.09% FTSE 250 15,837.69 +0.30% The FTSE 100 was more or less flat by midday on Friday after trading within a narrow ran
Read moreFriday broker round-up UPDATE
7th Feb 2014 09:30
Acal: N+1 Singer initiates with a target price of 380p and a buy recommendation. AstraZeneca: Societe Generale ups target price from 3030p to 3126p, but still recommends selling. Barratt Developments: Deutsche Bank raises target price from 394p to 480p keeping a buy recommendation. Beazley: Canac
Read moreLondon open: Markets pause ahead of US jobs data, stocks flat
7th Feb 2014 08:37
- Non-farm payrolls estimated at 180,000 - China services PMI falls to 50.9 - Tate & Lyle upgraded by JPMorgan to 'overweight' - Shires stops development of depression drug techMARK 2,781.99 +0.10% FTSE 100 6,561.78 +0.05% FTSE 250 15,827.61 +0.24% The FTSE 100 was broadly flat on Friday morning w
Read moreLondon close: Markets bounce back on ECB promise
6th Feb 2014 16:50
- ECB ready and willing to act - Vodafone and SuperGroup lead gains - All eyes on Friday´s US jobs report techMARK 2,779.24 +1.25% FTSE 100 6,558.28 +1.55% FTSE 250 15,789.91 +1.47% After a cautious start, UK markets pushed firmly into positive territory on Thursday after European Central Bank (EC
Read more